SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury - Quaterly Results

22 Jun 2022 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 1343.94 millions, about 11.58% up against Rs. 1204.47 millions recorded during the year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 825.45 millions grew from Rs.-89.55 millions Operating profit Margin for the quarter ended March 2022 improved to 134.54% as compared to -5.55% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1343.94 1204.47 11.58 5111.86 3925.18 30.23 5111.86 3925.18 30.23
Other Income 6.41 12.12 -47.11 15.08 24.04 -37.27 15.08 24.04 -37.27
PBIDT 134.54 -5.55 -2524.14 368.21 204.24 80.28 368.21 204.24 80.28
Interest 47.89 57.88 -17.26 206.11 230.75 -10.68 206.11 230.75 -10.68
PBDT 850.33 -63.43 -1440.58 925.78 -26.51 -3592.19 925.78 -26.51 -3592.19
Depreciation 30.02 25.87 16.04 114.50 97.54 17.39 114.50 97.54 17.39
PBT 820.31 -89.30 -1018.60 811.28 -124.05 -753.99 811.28 -124.05 -753.99
TAX -5.14 0.25 -2156.00 -3.46 2.00 -273.00 -3.46 2.00 -273.00
Deferred Tax -5.14 -22.43 -77.08 -3.46 -20.68 -83.27 -3.46 -20.68 -83.27
PAT 825.45 -89.55 -1021.78 814.74 -126.05 -746.36 814.74 -126.05 -746.36
Equity 326.66 250.15 30.59 326.66 250.15 30.59 326.66 250.15 30.59
PBIDTM(%) 10.01 -0.46 -2272.50 7.20 5.20 38.43 7.20 5.20 38.43

Wanbury Share Price

254.00 2.00 (0.79%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×